獸用疫苗市場規模、佔有率、成長分析、按產品、給藥途徑和地區 - 產業預測，2024-2031 年

2022年全球獸用疫苗市場規模為124億美元，從2023年的135.9億美元成長到2031年的283億美元，複合年成長率預計為9.60%。

動物疾病發病率的增加以及牲畜數量的增加極大地促進了反芻動物疫苗，特別是牛疫苗的全球採用。由於牲畜對於肉類、牛奶、羊毛和皮革的生產至關重要，因此迫切需要接種疫苗來預防損害牲畜健康和生產力的疾病，例如狂犬病、馬流感和口蹄疫。對糧食安全的日益擔憂和畜牧業產量的激增進一步推動了對這些疫苗的需求。隨著消費者偏好隨著人口成長而變化，對畜產品的需求也在改變。此外，疫苗技術的進步和疾病的頻繁爆發正在重塑市場動態，並促進牲畜疫苗產業的持續擴張。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特分析與影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境
• 專利分析
• 案例研究

動物疫苗市場規模：依產品分類

• 市場概況
• 減毒活病毒疫苗
• 去活化疫苗
• 次單位疫苗
• DNA疫苗
• 重組疫苗

獸用疫苗市場規模：依給藥途徑分類

• 市場概況
• 皮下的
• 肌肉注射
• 鼻內

動物疫苗市場規模：依動物類型

• 市場概況
• 家畜
  • 家禽
  • 魚
  • 反芻動物
  • 豬
• 伴同性
  • 狗
  • 貓科動物
  • 其他

動物疫苗市場規模：依分銷管道分類

• 市場概況
• 零售
• 電子商務
• 醫院/診所藥房

動物疫苗市場規模：按地區

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Zoetis
• Merck & Co., Inc.
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Inc.
• Bayer AG
• Virbac
• Ceva
• HIPRA
• Hester Biosciences Limited
• Biogenesis Bago
• Vaxxinova
• IDT Biologika GmbH
• Bimeda Animal Health
• BravoVax
• MSD Animal Health
• Agrovet Market Animal Health
• Anicon Labor GmbH

結論和建議

Global Animal Vaccines Market size was valued at USD 12.4 billion in 2022 and is poised to grow from USD 13.59 billion in 2023 to USD 28.30 billion by 2031, growing at a CAGR of 9.60% during the forecast period (2024-2031).

The rising incidence of animal diseases, coupled with a growing livestock population, is significantly boosting the global acceptance of ruminant vaccines, especially for cattle. With animals being vital for producing meat, milk, wool, and leather, there is an increased urgency for vaccination to prevent diseases like rabies, equine influenza, and foot-and-mouth disease that compromise animal health and productivity. The escalating concerns surrounding food security and the surge in animal husbandry practices are further driving demand for these vaccines. As consumer preferences evolve alongside population growth, the appetite for livestock products intensifies. Moreover, advancements in vaccine technology and frequent disease outbreaks are reshaping market dynamics, contributing to continued expansion in the livestock vaccination sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Vaccines Market Segmental Analysis

Global Animal Vaccines Market is segmented by Product, Route of Administration, Animal Type, Distribution Channel, and region. Based on Product, the market is segmented into Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, and Recombinant Vaccines. Based on Route of Administration, the market is segmented into Subcutaneous, Intramuscular, and Intranasal. Based on Animal Type, the market is segmented into Livestock, and Companion Based on Distribution Channel, the market is segmented into Retail, E-Commerce, and Hospital/ Clinic Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Animal Vaccines Market

The Global Animal Vaccines market is significantly driven by the rising incidence of zoonotic diseases, which have a detrimental impact on human health and underscore the urgent need for effective animal immunization. The escalating threat posed by emerging and exotic diseases compromises not only human and animal well-being but also jeopardizes food security. With increasing human and animal populations, coupled with environmental changes and the globalization of trade and travel, there are heightened risks for pathogen transmission across species. Furthermore, advancements in technology have transformed animal vaccination practices, leading to substantial R&D breakthroughs. Traditional vaccination methods have paved the way for the development of recombinant vaccines, which offer enhanced safety benefits by eliminating exposure to live pathogens. These dynamics collectively drive the demand for innovative animal vaccines in today's market.

Restraints in the Global Animal Vaccines Market

The Global Animal Vaccines market faces significant constraints, particularly in developing regions such as Africa, Asia, and Latin America, where an estimated 600-900 million smallholder farmers manage livestock. The adoption of animal vaccinations among these farmers is hindered by multiple challenges, including a lack of awareness regarding the advantages of vaccination, financial limitations that prevent access to immunization products, and the inadequate supply chain that restricts availability. As a result, many livestock animals owned by smallholder farmers succumb to various diseases, leading to further economic hardships for these communities. Governments and organizations are implementing strategies to enhance the accessibility, availability, and affordability of animal vaccination to improve livestock health in these areas.

Market Trends of the Global Animal Vaccines Market

The Global Animal Vaccines market is poised for substantial growth, driven by a surge in public-private funding for targeted research initiatives and a heightened prevalence of animal diseases. Technological advancements are facilitating product innovations, presenting lucrative opportunities for market players. Future growth will be further supported by increasing strategic alliances, enhanced internet penetration, and heightened concerns regarding zoonotic diseases. Additionally, advancements in diagnostics and therapeutics in developing regions, coupled with rising per capita healthcare spending, will amplify market demand. Collectively, these factors are positioning the animal vaccines sector as a critical market trend in the evolving landscape of veterinary healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Animal Vaccines Market Size by Product & CAGR (2024-2031)

• Market Overview
• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines

Global Animal Vaccines Market Size by Route of Administration & CAGR (2024-2031)

• Market Overview
• Subcutaneous
• Intramuscular
• Intranasal

Global Animal Vaccines Market Size by Animal Type & CAGR (2024-2031)

• Market Overview
• Livestock
  • Poultry
  • Aqua
  • Ruminants
  • Swine
• Companion
  • Canine
  • Feline
  • Others

Global Animal Vaccines Market Size by Distribution Channel & CAGR (2024-2031)

• Market Overview
• Retail
• E-Commerce
• Hospital/ Clinic Pharmacy

Global Animal Vaccines Market Size & CAGR (2024-2031)

• North America, (Product, Route of Administration, Animal Type, Distribution Channel)
  • US
  • Canada
• Europe, (Product, Route of Administration, Animal Type, Distribution Channel)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product, Route of Administration, Animal Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product, Route of Administration, Animal Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product, Route of Administration, Animal Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HIPRA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hester Biosciences Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogenesis Bago
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vaxxinova
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDT Biologika GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bimeda Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BravoVax
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agrovet Market Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anicon Labor GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation